biotech partnerships

Joint ventures (JVs) can be a game-changer for pharmaceutical companies—offering faster market entry, shared risks, and complementary expertise. However, 50–70% of pharma JVs still fail due to poor planning, misaligned goals, or weak operational execution. This guide explores: Why Pharma JVs Are on the Rise—and When to Use Them Top 5 Reasons Companies Form Pharma…